Sorry, you need to enable JavaScript to visit this website.

Skip to main content

Search

Collaboration with TB Alliance

Collaboration With the Global Alliance for TB Drug Development

More than 480,000 new cases of multi-drug resistant tuberculosis (MDR-TB) were reported worldwide in 2013 , and only 20 percent of MDR-TB patients were enrolled in treatment.

Our agreements and partnerships aim to improve access, advance new treatment regimens and foster responsible access. In 2009, we announced a landmark collaboration with the Global Alliance for TB Drug Development (TB Alliance). In September 2014, we announced that we will be providing a grant to Harvard Medical School to support a two-year research, policy and advocacy program to address significant unmet needs in drug-resistant TB. We will continue to establish additional collaborations with key stakeholders to advance public health goals.

Partnerships

Partnerships

Wendy Olsen, lincs
Wendy Olsen, lincs